110 related articles for article (PubMed ID: 14562180)
1. HLA class II antigen expression in conjunctival precancerous lesions and squamous cell carcinomas.
Abhyankar D; Lakshmi SA; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2003 Sep; 27(3):151-5. PubMed ID: 14562180
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte class I antigen and beta2-microglobulin expression in conjunctival dysplasia, carcinoma in situ, and squamous cell carcinoma.
Krishnakumar S; Lakshmi SA; Pusphparaj V; Iyer A; Abhyankar D; Biswas J
Cornea; 2005 Apr; 24(3):337-41. PubMed ID: 15778609
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
4. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites.
Mattijssen V; De Mulder PH; Schalkwijk L; Manni JJ; Van 't Hof-Grootenboer B; Ruiter DJ
Int J Cancer Suppl; 1991; 6():95-100. PubMed ID: 2066187
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
6. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
7. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
8. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
9. HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features.
Krishnakumar S; Abhyankar D; Lakshmi SA; Shanmugam MP; Pushparaj V; Biswas J
Exp Eye Res; 2003 Aug; 77(2):175-80. PubMed ID: 12873447
[TBL] [Abstract][Full Text] [Related]
10. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
Cromme FV; Meijer CJ; Snijders PJ; Uyterlinde A; Kenemans P; Helmerhorst T; Stern PL; van den Brule AJ; Walboomers JM
Br J Cancer; 1993 Jun; 67(6):1372-80. PubMed ID: 8390286
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
12. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells in precancerous lesions of the larynx.
Sprinzl GM; Hussl B; Obrist P; Yoneda K; Thumfart WF; Romani N; Schrott-Fischer A
Laryngoscope; 2000 Jan; 110(1):13-8. PubMed ID: 10646708
[TBL] [Abstract][Full Text] [Related]
15. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
[TBL] [Abstract][Full Text] [Related]
16. [Immunocytochemical detection of involucrin in precancerous and cancerous non-pigmented conjunctival tumors].
Holbach L; Hofmann C; Völcker HE; Naumann GO
Klin Monbl Augenheilkd; 1986 Aug; 189(2):128-32. PubMed ID: 3531699
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of the inflammatory infiltrate associated with equine squamous cell carcinoma.
Pérez J; Mozos E; Martín MP; Day MJ
J Comp Pathol; 1999 Nov; 121(4):385-97. PubMed ID: 10542127
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
Liu Q; Hao C; Su P; Shi J
Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
[TBL] [Abstract][Full Text] [Related]
20. HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck.
Houck JR; Sexton FM; Zajdel G
Arch Otolaryngol Head Neck Surg; 1990 Oct; 116(10):1181-5. PubMed ID: 2206503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]